{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:12:52Z","timestamp":1782551572577,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.clgc.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T22:32:29Z","timestamp":1464647549000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-5954","authenticated-orcid":false,"given":"Jae Min","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Koo","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungnam","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wan","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2601-1093","authenticated-orcid":false,"given":"Ho Kyung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2016.05.006_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2016.05.006_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2016.05.006_bib3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/01.ane.0000167775.46192.e9","article-title":"The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study","volume":"101","author":"Agarwal","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clgc.2016.05.006_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/bja\/aem232","article-title":"Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy","volume":"99","author":"Tauzin-Fin","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clgc.2016.05.006_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/ACO.0b013e32834c7b44","article-title":"Delirium in the postanaesthesia period","volume":"24","author":"Guenther","year":"2011","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.clgc.2016.05.006_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/nau.22617","article-title":"Fourth international consultation on incontinence-research society 2013","volume":"33","author":"Abrams","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.clgc.2016.05.006_bib7","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1213\/01.ane.0000281154.03887.2b","article-title":"An evaluation of the efficacy of gabapentin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study","volume":"105","author":"Agarwal","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clgc.2016.05.006_bib8","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.eururo.2007.05.027","article-title":"Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg","volume":"52","author":"Chapple","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2016.05.006_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1464-410X.2004.04606.x","article-title":"Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder","volume":"93","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2016.05.006_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00210-002-0554-x","article-title":"M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland","volume":"366","author":"Ikeda","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.clgc.2016.05.006_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.eururo.2004.11.004","article-title":"Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome","volume":"47","author":"Haab","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2016.05.006_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2005.06.007","article-title":"Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis","volume":"48","author":"Abrams","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2016.05.006_bib13","first-page":"66","article-title":"Recent trends in pharmacologic treatment of cancer pain","volume":"55","author":"Sohn","year":"2012","journal-title":"J\u00a0Korean Med Assoc"},{"key":"10.1016\/j.clgc.2016.05.006_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.annfar.2010.12.009","article-title":"Predictors of catheter-related bladder discomfort in the post-anaesthesia care unit","volume":"30","author":"Binhas","year":"2011","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.clgc.2016.05.006_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/bja\/ael003","article-title":"Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study","volume":"96","author":"Agarwal","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clgc.2016.05.006_bib16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.urology.2011.11.050","article-title":"Efficacy of gabapentin for prevention of postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor","volume":"79","author":"Bala","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2016.05.006_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1089\/end.2014.0670","article-title":"Management of catheter-related bladder discomfort in patients who underwent elective surgery","volume":"29","author":"Bai","year":"2015","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.clgc.2016.05.006_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.urology.2014.02.034","article-title":"Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors","volume":"84","author":"Zhang","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2016.05.006_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.eururo.2009.04.018","article-title":"Impact of percutaneous suprapubic tube drainage on patient discomfort after radical prostatectomy","volume":"56","author":"Krane","year":"2009","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876731630132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876731630132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:27:01Z","timestamp":1761564421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155876731630132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S155876731630132X"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2016.05.006","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}